Search

Author/Creator Galstyan, Gagik R.

1. Glycaemic benefit of iGlarLixi in insulin‐naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan‐O randomized trial. Issue 8 (18th June 2019)

Authors:
Davies, Melanie J.; Russell‐Jones, David; Barber, Thomas M.; Lavalle‐González, Fernando J.; Galstyan, Gagik R.; Zhu, Dalong; Baxter, Mike; Dessapt‐Baradez, Cecile; McCrimmon, Rory J.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 21:Issue 8(2019)
Page Start:
1967
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Lifestyle modification program, LIFE is LIGHT, in patients with type 2 diabetes mellitus and obesity: Results from a 48‐week, multicenter, non‐randomized, parallel‐group, open‐label study. (9th April 2021)

Authors:
Galstyan, Gagik R.; Valeeva, Farida V.; Motkova, Svetlana I.; Surkova, Elena V.; Savelyeva, Larisa V.; Rudina, Larisa M.; Ramanathan, Krishnan; Sokareva, Ekaterina; Bondareva, Kristina; Shestakova, Marina V.
Journal:
Obesity science and practice
Issue:
Volume 7:Number 4(2021)
Page Start:
368
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa. (February 2021)

Authors:
Giorgino, Francesco; Bhana, Sindeep; Czupryniak, Leszek; Dagdelen, Selcuk; Galstyan, Gagik R.; Janež, Andrej; Lalić, Nebojsa; Nouri, Nassim; Rahelić, Dario; Stoian, Anca Pantea; Raz, Itamar
Journal:
Diabetes research and clinical practice
Issue:
Volume 172(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗